All News

    Understanding Financial Toxicity and Navigating the System During Cancer

    August 3rd 2025, 2:00pm

    Article

    Kasey Bowden highlights the importance of recognizing financial toxicity and shares advice with those who feel lost in the healthcare system during cancer.

    What Is Immunotherapy-Induced Diabetes?

    August 2nd 2025, 6:00pm

    Video

    CURE spoke with an expert to learn what patients need to know about immunotherapy-induced diabetes.

    Breaking Down Every FDA Approval Across Oncology During July 2025

    August 2nd 2025, 2:00pm

    Article

    In July of 2025, the U.S. Food and Drug Administration approved various anti-cancer treatments and therapeutic approaches across a range of disease types.

    What Patients With Cancer Need to Know About Bladder Removal Surgery

    August 1st 2025, 9:00pm

    Article

    CURE spoke with experts about radical cystectomy, or surgical removal of the bladder, for patients with bladder cancer.

    Minimally Invasive Surgery Transforms Lung Cancer Recovery

    August 1st 2025, 8:00pm

    Video

    Robotic and video-assisted thoracic surgery reduces recovery time for those with lung cancer, allowing some to leave the hospital the day after surgery.

    BMT-CARE App Improves Quality of Life and Mental Health for Caregivers

    August 1st 2025, 7:00pm

    Article

    BMT-CARE app boosted quality of life, lowered depression and PTSD symptoms, and improved coping mechanisms for caregivers of stem cell transplant patients.

    Understanding Epithelioid Hemangioendothelioma: A Rare Vascular Cancer

    August 1st 2025, 5:00pm

    Article

    Dr. Michael Wagner covers the basics of epithelioid hemangioendothelioma, a rare vascular cancer, spanning symptoms, diagnosis, treatment options and more.

    How Robotic Surgery Can Impact Outcomes For Those With Lung Cancer

    August 1st 2025, 4:00pm

    Article

    CURE spoke with a thoracic surgeon about the impact of minimally invasive surgery for patients.

    Oncolytic Virus Wins FDA Fast Track Designation in Soft Tissue Sarcoma

    August 1st 2025, 2:59pm

    Article

    The U.S. FDA has granted fast track designation to treatment with CLD-201, an oncolytic virus, for patients with soft tissue sarcoma.

    The Significance of the Datroway FDA Approval in EGFR+ NSCLC

    August 1st 2025, 1:00pm

    Video

    Dr. Jacob Sands discusses the significance of the FDA approval of Datroway for the treatment of patients with locally advanced or metastatic EGFR+ NSCLC.